drugset / Trial / NCT05317611
Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.
RandomizedParallel-groupDouble-blindTreatment
Summary
Study the effect of intraperitoneal instillation vs intravenous ondansetron on PONV added to intraperitoneal bupivacaine for enhanced recovery and to decrease incidence of PONV after laparoscopic surgeries.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2025-01-15
- Completion
- 2025-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ondansetron | Other / unclassified | 4 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 100 mg | Other |
Indications
No indication recorded.